
    
      All participants will continue medications for 4 weeks, then stop using interventional
      medication and still take INS (2 puffs in each nostril twice daily) and OAH (1 tablet once
      daily) for 2 more weeks. Then, all participants will come for the last visit to see whether
      rebound nasal symptoms occur. Participants will be asked to record nasal symptom diary card,
      and nasal peak inspiratory flow. Rhinoconjunctivitis Quality of life Questionnaire (Rcq) will
      be recorded during visit.
    
  